|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
136,480,000 |
Market
Cap: |
3.50(B) |
Last
Volume: |
503,160 |
Avg
Vol: |
498,450 |
52
Week Range: |
$25.43 - $34.14 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2008-08-21 |
4 |
OE |
$6.16 |
$113,262 |
D/D |
18,398 |
23,128 |
|
- |
|
Arkin Moshe |
Director |
|
2008-08-21 |
4 |
S |
$35.63 |
$4,274,131 |
I/I |
(119,563) |
9,713,039 |
|
- |
|
Arkin Moshe |
Director |
|
2008-08-21 |
4 |
S |
$35.50 |
$1,779,934 |
I/I |
(50,060) |
9,832,602 |
|
- |
|
Arkin Moshe |
Director |
|
2008-08-21 |
4 |
S |
$35.88 |
$3,137,056 |
I/I |
(87,264) |
9,625,775 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-21 |
4 |
S |
$35.50 |
$106,251 |
I/I |
(2,992) |
2,894,603 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2008-08-20 |
4 |
S |
$35.47 |
$68,681 |
D/D |
(1,934) |
5,030 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2008-08-20 |
4 |
OE |
$6.16 |
$11,906 |
D/D |
1,934 |
6,964 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2008-08-20 |
4 |
S |
$35.41 |
$409,883 |
D/D |
(11,567) |
15,694 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2008-08-20 |
4 |
OE |
$14.69 |
$148,850 |
D/D |
10,000 |
25,694 |
|
- |
|
Arkin Moshe |
Director |
|
2008-08-20 |
4 |
S |
$35.50 |
$1,532,151 |
I/I |
(43,113) |
9,882,662 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-20 |
4 |
S |
$35.50 |
$1,673,526 |
I/I |
(47,008) |
2,879,595 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-19 |
4 |
S |
$35.93 |
$1,860,054 |
I/I |
(51,636) |
2,950,303 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-19 |
4 |
S |
$35.62 |
$12,905,344 |
I/I |
(361,527) |
3,119,282 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-19 |
4 |
S |
$35.39 |
$4,205,864 |
I/I |
(117,343) |
3,001,939 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-19 |
4 |
S |
$36.22 |
$206,740 |
I/I |
(5,700) |
2,944,603 |
|
- |
|
Jandernoa Michael J |
Director |
|
2008-08-19 |
4 |
S |
$35.50 |
$12,921,007 |
I/I |
(363,794) |
3,480,809 |
|
- |
|
Tomshack James |
Senior VP of CHC Sales |
|
2008-08-19 |
4 |
S |
$35.50 |
$1,420,961 |
D/D |
(40,000) |
4,500 |
|
- |
|
Tomshack James |
Senior VP of CHC Sales |
|
2008-08-19 |
4 |
OE |
$9.84 |
$547,360 |
D/D |
40,000 |
44,500 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2008-08-19 |
4 |
S |
$35.61 |
$356,560 |
D/D |
(10,000) |
5,441 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2008-08-19 |
4 |
D |
$35.68 |
$9,812 |
D/D |
(275) |
15,441 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2008-08-19 |
4 |
OE |
$9.84 |
$108,240 |
D/D |
11,000 |
15,716 |
|
- |
|
Gibbons David T |
Director |
|
2008-08-08 |
4 |
AS |
$35.36 |
$531,295 |
D/D |
(15,000) |
138,920 |
|
- |
|
Gibbons David T |
Director |
|
2008-07-25 |
4 |
AS |
$35.48 |
$253,278 |
D/D |
(7,100) |
161,820 |
|
- |
|
Gibbons David T |
Director |
|
2008-07-25 |
4 |
AS |
$36.26 |
$123,540 |
D/D |
(3,400) |
153,920 |
|
- |
|
Gibbons David T |
Director |
|
2008-07-25 |
4 |
AS |
$35.81 |
$162,116 |
D/D |
(4,500) |
157,320 |
|
- |
|
1400 Records found
|
|
Page 38 of 56 |
|
|